Huixia Jin

Huixia Jin

Auto-generated profile, based on publicly available information

Huixia Jin

Durham, NC

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Research and Reports in Urology
Verified
Journal Article
Open access
PDF file
BIBrian M Inouye
Brian M Inouye
FHFrancis Monroe Hughes
Francis Monroe Hughes
HJHuixia Jin
Huixia Jin
RLRobin Lütolf
Robin Lütolf
KPKunal C Potnis
Kunal C Potnis
JPJ Todd Purves
J Todd Purves
Purpose: Diabetes is a grave and progressive condition characterized by debilitating complications. Diabetic bladder dysfunction (DBD) is a very common complication with no specific treatments currently available. Unlike other tissues affected by this disease, the bladder is subjected to two independent insults; 1) polyuria, created by the osmotic effects of glucose in the urine, and 2) hyperglycemia itself. Based on our understanding of inflammation as a major contributor to the underlying organ damage in several other diabetic complications, its presence in the bladder during DBD and the contribution of polyuria and hyperglycemia to its development were assessed. Methods: Awake, restrained cystometry was performed on wild type C57BL/6 mice and diabetic (Akita) mice on a C57BL/6 background at 15 weeks of age. A subgroup of the Akita mice were treated with phlorizin, an inhibitor of sodium-glucose linked transporter types 1 and 2 that prevents glucose reabsorption in the kidney. All groups were assessed for serum glucose, 4-hour voiding totals, and inflammation in the bladder (Evans blue assay). Results: Akita mice develop cystometrically-defined DBD by 15 weeks of age, as evidenced by an increase in urinary frequency, a decrease in voiding volume, and an increase in post-voiding residual volume. Phlorizin effectively normalized serum glucose in these animals while increasing the urine output. Inflammation in the bladder was present in the diabetic animals at this time point, but not detectable in animals receiving phlorizin. Conclusion: Inflammation in the bladder of diabetic mice correlates with the development of DBD and is triggered by hyperglycemia, not polyuria.

29 June 2020 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
FHFrancis Monroe Hughes
Francis Monroe Hughes
NHNathan A. Hirshman
Nathan A. Hirshman
HMHamza A. Malick
Hamza A. Malick
SWSimon W. White
Simon W. White
HJHuixia Jin
Huixia Jin
JPJ. Todd Purves
J. Todd Purves

1 November 2019 in Research and Reports in Urology
Verified
Journal Article
Open access
PDF file
SHShelby N Harper
Shelby N Harper
PLPatrick D Leidig
Patrick D Leidig
FHFrancis Monroe Hughes
Francis Monroe Hughes
HJHuixia Jin
Huixia Jin
JPJ Todd Purves
J Todd Purves
Objective: To investigate the in vitro activation of the NLRP3 inflammasome within bladder urothelium by stone-forming components. Further, to describe the contributions of reactive oxygen species (ROS) and thioredoxin-interacting protein (TXNIP), an important structural component of the inflammasome, to this activation. Methods: Urothelial cells were harvested and incubated overnight. For agonist studies, cells were treated with varying concentrations of calcium pyrophosphate (CPPD) and monosodium urate (MSU). For inhibitor studies, cells were treated with either N-acetylcysteine (NAC) (1 hr) or Verapamil (4 hrs) prior to incubation with either CPPD (62.5 ug/mL) or MSU (1.25 ug/mL) for 24 hrs. Untreated controls were incubated with ATP (1.25 mM) for 1 hr to maximally stimulate NLRP3 inflammasome activity (measured as caspase-1 cleavage of the fluorogenic substrate Ac-YVAD-AFC). Results are reported as a percentage of maximum ATP response. Results: CPPD and MSU activate caspase-1 in urothelial cells in a dose-dependent manner, reaching ∼50% and ∼25% of the ATP response, respectively. Pre-treatment with the general ROS scavenger NAC reduces this activation in a dose-dependent manner. Additionally, activation was suppressed through treatment with Verapamil, a known downregulator of TXNIP expression. Conclusion: The stone components CPPD and MSU activate NLRP3 in an ROS and TXNIP-dependent manner in bladder urothelium. These findings demonstrate the importance of ROS and TXNIP, and suggest that targeting either may be a way to decrease stone-dependent NLRP3 inflammation within the bladder.

1 July 2023 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
FHFrancis Monroe Hughes
Francis Monroe Hughes
AAArmand Allkanjari
Armand Allkanjari
MOMichael R. Odom
Michael R. Odom
JMJack E. Mulcrone
Jack E. Mulcrone
HJHuixia Jin
Huixia Jin
JPJ. Todd Purves
J. Todd Purves
In this study, we show that diabetic bladder dysfunction (the most common diabetic complication) manifests through different mechanisms that may be related to severity of hyperglycemia and/or sex. Male Akita mice, which have severe hyperglycemia, develop bladder underactivity as a result of a decrease in efferent neurotransmitter release that is independent of inflammation. This contrasts with females, who have milder hyperglycemia, where diabetic bladder dysfunction progresses from overactivity to underactivity in an inflammation-dependent manner.

16 August 2024 in Continence
Verified
Journal Article
Open access
ALAustin J. Livingston
Austin J. Livingston
JPJ. Todd Purves
J. Todd Purves
MOMichael R. Odom
Michael R. Odom
HJHuixia Jin
Huixia Jin
FHFrancis Monroe Hughes
Francis Monroe Hughes
Diabetic bladder dysfunction (DBD) is the most common diabetic complication. Patients present with overactive symptoms, underactive symptoms, or both. While strict glucose control may be expected to reverse DBD, prior studies have not been supportive. However, we hypothesize that strict control, soon after hyperglycemia appears, can prevent DBD development. Moreover, 50% of adult diabetics are poorly-controlled and it is unknown how this effects development of DBD. Thus, we investigated the effect of early glucose control (poor and strict) on DBD in male Akita diabetic mice (type 1). NLRP3-induced inflammation is critical to development of DBD in female Akita. Therefore, we also hypothesized that targeting NLRP3 may control or prevent DBD in male Akita, especially in a poorly-controlled population. Akita mice (±NLRP3) were stratified into uncontrolled, poorly-controlled and strictly-controlled diabetic groups using insulin treatment (0, 0.125 or 0.25 U/day). Mice were assessed at 15 weeks for blood glucose, HbA1c, Evans blue dye extravasation (a marker of capillary permeability/inflammation) and bladder function. Blood glucose was elevated in diabetics, reduced in an insulin dose-dependent manner, and not affected by NLRP3 deletion. HbA1c levels followed a similar course but were more sensitive to insulin levels. Evans blue dye extravasation was prevented with glucose control and absent in NLRP3-/- mice. Diabetics exhibited signs of underactive bladder (increased void volume, decreased frequency) that was attenuated in the uncontrolled group but absent in the well-controlled group. Deleting NLRP3 did not affect voiding function. Male Akita mice develop an underactive-like bladder, independent of NLRP3, which can be prevented with glucose control.

20 July 2024 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
FHFrancis Monroe Hughes
Francis Monroe Hughes
SHShelby N. Harper
Shelby N. Harper
HJHuixia Jin
Huixia Jin
MOMichael R. Odom
Michael R. Odom
JPJ. Todd Purves
J. Todd Purves